Quinolizium methylsulphate
Alternative Names: NBQLatest Information Update: 14 Jul 1998
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Jul 1998 Profile reviewed
- 14 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 07 Apr 1995 Preclinical development for Cancer in USA (Unknown route)